These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26499396)
41. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells. Armakolas A; Philippou A; Panteleakou Z; Nezos A; Sourla A; Petraki C; Koutsilieris M Prostate; 2010 Aug; 70(11):1233-42. PubMed ID: 20564425 [TBL] [Abstract][Full Text] [Related]
42. Placenta-specific INSL4 expression is mediated by a human endogenous retrovirus element. Bièche I; Laurent A; Laurendeau I; Duret L; Giovangrandi Y; Frendo JL; Olivi M; Fausser JL; Evain-Brion D; Vidaud M Biol Reprod; 2003 Apr; 68(4):1422-9. PubMed ID: 12606452 [TBL] [Abstract][Full Text] [Related]
43. Expression of the human relaxin H1 gene in the decidua, trophoblast, and prostate. Hansell DJ; Bryant-Greenwood GD; Greenwood FC J Clin Endocrinol Metab; 1991 Apr; 72(4):899-904. PubMed ID: 2005217 [TBL] [Abstract][Full Text] [Related]
44. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412 [TBL] [Abstract][Full Text] [Related]
45. Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Coutinho-Camillo CM; Salaorni S; Sarkis AS; Nagai MA Cancer Genet Cytogenet; 2006 Apr; 166(2):130-8. PubMed ID: 16631469 [TBL] [Abstract][Full Text] [Related]
47. The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7. Vinall RL; Tepper CG; Shi XB; Xue LA; Gandour-Edwards R; de Vere White RW Oncogene; 2006 Mar; 25(14):2082-93. PubMed ID: 16434975 [TBL] [Abstract][Full Text] [Related]
49. Identification and validation of novel androgen-regulated genes in prostate cancer. Velasco AM; Gillis KA; Li Y; Brown EL; Sadler TM; Achilleos M; Greenberger LM; Frost P; Bai W; Zhang Y Endocrinology; 2004 Aug; 145(8):3913-24. PubMed ID: 15131019 [TBL] [Abstract][Full Text] [Related]
50. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537 [TBL] [Abstract][Full Text] [Related]
51. Overexpression of prostate-specific TMPRSS2(exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer. Hermans KG; Boormans JL; Gasi D; van Leenders GJ; Jenster G; Verhagen PC; Trapman J Clin Cancer Res; 2009 Oct; 15(20):6398-403. PubMed ID: 19825963 [TBL] [Abstract][Full Text] [Related]
52. Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue. Luo JH; Liu S; Zuo ZH; Chen R; Tseng GC; Yu YP Am J Pathol; 2015 Jul; 185(7):1834-45. PubMed ID: 25963990 [TBL] [Abstract][Full Text] [Related]
53. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP. Fujinami K; Uemura H; Ishiguro H; Kubota Y Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554 [TBL] [Abstract][Full Text] [Related]
54. Novel fusion transcripts in bladder cancer identified by RNA-seq. Kekeeva T; Tanas A; Kanygina A; Alexeev D; Shikeeva A; Zavalishina L; Andreeva Y; Frank GA; Zaletaev D Cancer Lett; 2016 May; 374(2):224-8. PubMed ID: 26898937 [TBL] [Abstract][Full Text] [Related]
55. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer. Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593 [TBL] [Abstract][Full Text] [Related]
56. Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Yeh AH; Jeffery PL; Duncan RP; Herington AC; Chopin LK Clin Cancer Res; 2005 Dec; 11(23):8295-303. PubMed ID: 16322288 [TBL] [Abstract][Full Text] [Related]
57. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440 [TBL] [Abstract][Full Text] [Related]
58. Identification of novel TMPRSS2:ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2. Tian TV; Tomavo N; Huot L; Flourens A; Bonnelye E; Flajollet S; Hot D; Leroy X; de Launoit Y; Duterque-Coquillaud M Oncogene; 2014 Apr; 33(17):2204-14. PubMed ID: 23708657 [TBL] [Abstract][Full Text] [Related]
59. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. He WW; Sciavolino PJ; Wing J; Augustus M; Hudson P; Meissner PS; Curtis RT; Shell BK; Bostwick DG; Tindall DJ; Gelmann EP; Abate-Shen C; Carter KC Genomics; 1997 Jul; 43(1):69-77. PubMed ID: 9226374 [TBL] [Abstract][Full Text] [Related]
60. Gene expression in the LNCaP human prostate cancer progression model: progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo. Chen Q; Watson JT; Marengo SR; Decker KS; Coleman I; Nelson PS; Sikes RA Cancer Lett; 2006 Dec; 244(2):274-88. PubMed ID: 16500022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]